Published in J Nucl Med on March 01, 2005
Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell (2008) 5.09
A prototype PET scanner with DOI-encoding detectors. J Nucl Med (2008) 2.54
Virtual-pinhole PET. J Nucl Med (2008) 2.37
A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res (2009) 2.30
Attenuation correction for small animal PET tomographs. Phys Med Biol (2005) 2.16
Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards. J Nucl Med (2009) 2.03
A method of image registration for small animal, multi-modality imaging. Phys Med Biol (2006) 1.75
Effects of system geometry and other physical factors on photon sensitivity of high-resolution positron emission tomography. Phys Med Biol (2007) 1.74
Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging (2009) 1.74
Performance evaluation of an Inveon PET preclinical scanner. Phys Med Biol (2009) 1.65
Micro insert: a prototype full-ring PET device for improving the image resolution of a small-animal PET scanner. J Nucl Med (2008) 1.62
Depth of interaction calibration for PET detectors with dual-ended readout by PSAPDs. Phys Med Biol (2008) 1.59
A prototype of very high resolution small animal PET scanner using silicon pad detectors. Nucl Instrum Methods Phys Res A (2007) 1.54
Application of silicon photomultipliers to positron emission tomography. Ann Biomed Eng (2011) 1.47
68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression. Eur J Nucl Med Mol Imaging (2008) 1.43
NEMA NU 4-2008 comparison of preclinical PET imaging systems. J Nucl Med (2012) 1.38
Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology (2009) 1.37
Dynamic PET denoising with HYPR processing. J Nucl Med (2010) 1.35
Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET. Eur J Nucl Med Mol Imaging (2009) 1.23
NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system. Phys Med Biol (2009) 1.22
Investigation of Depth of Interaction Encoding for a Pixelated LSO Array with a Single Multi-Channel PMT. IEEE Trans Nucl Sci (2009) 1.20
Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice. J Nucl Med (2005) 1.20
Performance evaluation of the Philips MOSAIC small animal PET scanner. Eur J Nucl Med Mol Imaging (2006) 1.19
In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders. J Neurosci (2011) 1.19
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS One (2012) 1.18
Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET. J Nucl Med (2009) 1.17
Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J Control Release (2008) 1.16
Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging (2010) 1.15
Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? Semin Nucl Med (2008) 1.15
PET/MRI hybrid imaging: devices and initial results. Eur Radiol (2008) 1.15
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nucl Med Biol (2009) 1.14
Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET. J Nucl Med (2006) 1.14
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo. Br J Cancer (2009) 1.13
Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. Mol Pharm (2009) 1.12
Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer. Nucl Med Biol (2008) 1.11
Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. Eur J Nucl Med Mol Imaging (2008) 1.08
Tapered LSO arrays for small animal PET. Phys Med Biol (2010) 1.06
Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation. J Nucl Med (2008) 1.06
Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease. Neurobiol Aging (2011) 1.06
Optimised motion tracking for positron emission tomography studies of brain function in awake rats. PLoS One (2011) 1.05
The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model. Eur J Nucl Med Mol Imaging (2007) 1.03
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice. J Nucl Med (2009) 1.02
High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability. J Nucl Cardiol (2011) 1.01
Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice. J Nucl Med (2009) 0.99
Estimation of the minimum detectable activity of preclinical PET imaging systems with an analytical method. Med Phys (2010) 0.98
Recent advances in small-animal cardiovascular imaging. J Nucl Med (2009) 0.97
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma. Nucl Med Biol (2007) 0.97
NEMA NU-4 performance evaluation of PETbox4, a high sensitivity dedicated PET preclinical tomograph. Phys Med Biol (2013) 0.96
Validation of nigrostriatal positron emission tomography measures: critical limits. Ann Neurol (2013) 0.95
Metabolic imaging of rat brain during pharmacologically-induced tinnitus. Neuroimage (2008) 0.94
Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice. Sci Rep (2013) 0.93
Performance evaluation of PETbox: a low cost bench top preclinical PET scanner. Mol Imaging Biol (2011) 0.92
Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol (2012) 0.91
Construction and evaluation of quantitative small-animal PET probabilistic atlases for [¹⁸F]FDG and [¹⁸F]FECT functional mapping of the mouse brain. PLoS One (2013) 0.90
Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging (2008) 0.89
Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT. Proc Am Thorac Soc (2005) 0.88
Immuno-positron emission tomography in cancer models. Semin Nucl Med (2010) 0.88
Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system. J Neurosci (2009) 0.87
In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia. J Med Chem (2008) 0.87
Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques. Ann Neurol (2013) 0.86
In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy. Circ Cardiovasc Imaging (2009) 0.86
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment. Neurobiol Dis (2011) 0.85
Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clin Cancer Res (2014) 0.85
Evaluation of frame-based and event-by-event motion-correction methods for awake monkey brain PET imaging. J Nucl Med (2014) 0.84
Use of a beta microprobe system to measure arterial input function in PET via an arteriovenous shunt in rats. EJNMMI Res (2011) 0.84
Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1. PLoS One (2013) 0.83
Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol (2012) 0.83
Wavelet denoising in voxel-based parametric estimation of small animal PET images: a systematic evaluation of spatial constraints and noise reduction algorithms. Phys Med Biol (2008) 0.83
Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer. Mol Imaging Biol (2013) 0.82
Biomedical engineering strategies in system design space. Ann Biomed Eng (2011) 0.82
Optimization of the Energy Window for PETbox4, a Preclinical PET Tomograph With a Small Inner Diameter. IEEE Trans Nucl Sci (2014) 0.82
Presynaptic selectivity of a ligand for serotonin 1A receptors revealed by in vivo PET assays of rat brain. PLoS One (2012) 0.81
Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence. Alcohol Clin Exp Res (2016) 0.81
FDG small animal PET permits early detection of malignant cells in a xenograft murine model. Eur J Nucl Med Mol Imaging (2006) 0.81
PET analysis of dopaminergic neurodegeneration in relation to immobility in the MPTP-treated common marmoset, a model for Parkinson's disease. PLoS One (2012) 0.80
Radiation dosimetry of [(18)F]VAT in nonhuman primates. EJNMMI Res (2015) 0.80
Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input. Nucl Med Biol (2013) 0.80
Effects of reflector and crystal surface on the performance of a depth-encoding PET detector with dual-ended readout. Med Phys (2014) 0.80
In vivo multi-tissue efficacy of peroxisome proliferator-activated receptor-γ therapy on glucose and fatty acid metabolism in obese type 2 diabetic rats. Obesity (Silver Spring) (2013) 0.79
Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenografts. Mol Imaging Biol (2015) 0.79
Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway. Am J Nucl Med Mol Imaging (2014) 0.79
The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PET. EJNMMI Res (2014) 0.78
Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice. Mol Imaging Biol (2013) 0.78
Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain. Eur J Nucl Med Mol Imaging (2012) 0.78
Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H3 receptors. EJNMMI Res (2016) 0.78
Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET. Eur J Nucl Med Mol Imaging (2015) 0.77
Determination of Fatty Acid Metabolism with Dynamic [11C]Palmitate Positron Emission Tomography of Mouse Heart In Vivo. Mol Imaging (2015) 0.77
Effects of amyloid precursor protein 17 peptide on the protection of diabetic encephalopathy and improvement of glycol metabolism in the diabetic rat. J Diabetes Res (2013) 0.77
Positron Emission Tomography with [(18)F]FLT Revealed Sevoflurane-Induced Inhibition of Neural Progenitor Cell Expansion in vivo. Front Neurol (2014) 0.76
Quantification of central substance P receptor occupancy by aprepitant using small animal positron emission tomography. Int J Neuropsychopharmacol (2014) 0.75
PET imaging-guided chemogenetic silencing reveals a critical role of primate rostromedial caudate in reward evaluation. Nat Commun (2016) 0.75
Central nervous system drug evaluation using positron emission tomography. Clin Psychopharmacol Neurosci (2011) 0.75
A small-animal pharmacokinetic/pharmacodynamic PET study of central serotonin 1A receptor occupancy by a potential therapeutic agent for overactive bladder. PLoS One (2013) 0.75
Local coordination state of rare earth in eutectic scintillators for neutron detector applications. Sci Rep (2015) 0.75
Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy Stress. Sci Rep (2016) 0.75
The effect of isoflurane on (18)F-FDG uptake in the rat brain: a fully conscious dynamic PET study using motion compensation. EJNMMI Res (2016) 0.75
[18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents. Eur J Nucl Med Mol Imaging (2015) 0.75
Investigation of optimization-based reconstruction with an image-total-variation constraint in PET. Phys Med Biol (2016) 0.75
Neuroimaging in Animal Seizure Models with (18)FDG-PET. Epilepsy Res Treat (2011) 0.75
A method for comparing intra-tumoural radioactivity uptake heterogeneity in preclinical positron emission tomography studies. EJNMMI Phys (2015) 0.75
MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging. Phys Med Biol (2003) 5.28
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med (2008) 4.54
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit (2009) 3.32
Performance evaluation of the microPET R4 PET scanner for rodents. Eur J Nucl Med Mol Imaging (2003) 2.47
Optimization and performance evaluation of the microPET II scanner for in vivo small-animal imaging. Phys Med Biol (2004) 2.41
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. Eur J Nucl Med Mol Imaging (2003) 2.25
Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci U S A (2010) 2.16
Gold nanocages as photothermal transducers for cancer treatment. Small (2010) 1.92
Registration of [18F]FDG microPET and small-animal MRI. Nucl Med Biol (2005) 1.89
Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. J Nucl Med (2007) 1.63
Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med (2008) 1.51
Minimally invasive method of determining blood input function from PET images in rodents. J Nucl Med (2006) 1.46
Instrumentation aspects of animal PET. Annu Rev Biomed Eng (2005) 1.40
NEMA NU 4-2008 comparison of preclinical PET imaging systems. J Nucl Med (2012) 1.38
Monte carlo simulations of dose from microCT imaging procedures in a realistic mouse phantom. Med Phys (2006) 1.35
18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. J Nucl Med (2007) 1.25
An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix. J Nucl Med (2008) 1.18
Cardiac PET imaging in mice with simultaneous cardiac and respiratory gating. Phys Med Biol (2005) 1.11
Preparation of high specific activity (86)Y using a small biomedical cyclotron. Nucl Med Biol (2005) 1.10
Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). J Nucl Med (2002) 1.09
Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody. J Nucl Med (2013) 1.06
Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. J Bone Miner Res (2010) 1.04
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl Med Biol (2003) 1.03
Quantitative accuracy of MAP reconstruction for dynamic PET imaging in small animals. Med Phys (2012) 1.02
A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours. Med Phys (2008) 1.02
Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. Nucl Med Biol (2006) 0.96
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione. J Nucl Med (2012) 0.92
Assessment of cellular proliferation in tumors by PET using 18F-ISO-1. J Nucl Med (2013) 0.90
Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals. Nucl Med Biol (2002) 0.89
Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line. J Nucl Med (2007) 0.89
Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys (2002) 0.89
Quantitative small animal PET imaging with nonconventional nuclides. Nucl Med Biol (2009) 0.87
Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer. Int J Nanomedicine (2012) 0.86
Advances in the production, processing and microPET image quality of technetium-94m. Nucl Med Biol (2006) 0.84
Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. Eur J Nucl Med Mol Imaging (2007) 0.84
Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1. PLoS One (2013) 0.83
Evaluation of transmission methodology and attenuation correction for the microPET Focus 220 animal scanner. Phys Med Biol (2006) 0.83
PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. Int J Radiat Oncol Biol Phys (2002) 0.83
Initial characterization of a dually radiolabeled peptide for simultaneous monitoring of protein targets and enzymatic activity. Nucl Med Biol (2012) 0.83
The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer. J Nucl Med (2013) 0.82
Shc depletion stimulates brown fat activity in vivo and in vitro. Aging Cell (2014) 0.82
Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2005) 0.79
Radiochemical synthesis, rodent biodistribution and tumor uptake, and dosimetry calculations of [¹¹C] methylated LY2181308. Mol Imaging Biol (2010) 0.79
Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans. J Nucl Med (2012) 0.78
Beyond whole-body imaging: advanced imaging techniques of PET/MRI. Clin Nucl Med (2015) 0.78
Dual-radiolabeled nanoparticle SPECT probes for bioimaging. Nanoscale (2015) 0.77
Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease. EJNMMI Res (2015) 0.77
Plant cystoliths: a complex functional biocomposite of four distinct silica and amorphous calcium carbonate phases. Chemistry (2012) 0.77
Production, processing and small animal PET imaging of titanium-45. Nucl Med Biol (2005) 0.77
Demonstration of intermittent ischemia and stunning in hibernating myocardium. J Nucl Cardiol (2013) 0.76
A scatter and randoms weighted (SRW) iterative PET reconstruction. Med Phys (2011) 0.75